Zenas BioPharma, Inc.

NASDAQ:ZBIO

Biotechnology

Healthcare
$25.04 +3.46%

+$0.64 today

Market cap
$1.70B
Beta
-0.69
P/E (TTM)
-2.5
EPS (TTM)
-$7.64
52W Low $8.91High $44.60

Volume 0.27M

Average 0.71M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$172.33M

FY 2025 · Annual

Investing Cash Flow

-$251.89M

FY 2025 · Annual

Financing Cash Flow

$215.28M

FY 2025 · Annual

-47.9% YoY

Cash Flow Statement

USD
Metric
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(119.28M)(37.12M)(156.99M)(377.74M)
Depreciation & Amortization78K113K137K(1.88M)
Deferred Income Tax0000
Stock-Based Compensation737K3.5M10.82M26.35M
Change in Working Capital7.97M(8.04M)25.43M951K
Accounts Receivables0000
Inventory0000
Accounts Payables1.09M(418K)11.74M(10.04M)
Other Working Capital6.88M(7.62M)13.69M10.99M
Other Non-Cash Items44.85M11.03M925K179.98M
Operating Cash Flow(65.65M)(30.53M)(119.67M)(172.33M)
Capital Expenditures(2.2M)(17K)(131K)(18K)
Acquisitions (Net)0000
Purchases of Investments00(36.42M)(417.76M)
Sales of Investments006M200.89M
Other Investing Activities(2M)00(35M)
Investing Cash Flow(2.2M)(17K)(30.55M)(251.89M)
Debt Repayment020M00
Common Stock Issued59.39M116K240.64M152.95M
Common Stock Repurchased0000
Dividends Paid0000
Other Financing Activities00(6.06M)62.34M
Financing Cash Flow59.39M20.12M412.96M215.28M
Effect of Forex Changes(41K)78K157K(252K)
Net Change in Cash(8.5M)(10.35M)262.89M(209.19M)
Free Cash Flow(67.85M)(30.55M)(119.81M)(172.35M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$377.7M
+ D&A-$1.9M
+ Stock-Based Comp$26.3M
+ Deferred Tax$0
+ Working Capital$951.0K
+ Other Non-Cash$180.0M
= Operating Cash Flow-$172.3M
- Capex-$18.0K
= Free Cash Flow-$172.4M

Analysis

FY2025 free cash flow is -$172.4M. FCF conversion is 45.6% of net income. Operating cash flow was -$172.3M, with capex of -$18.0K. The largest bridge item is Other Non-Cash at $180.0M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 6, 2026
424B5424B5 filingNov 6, 2026
SC 13G/ASC 13G/A filingNov 5, 2026
8-KCurrent reportNov 5, 2026
10-QQuarterly reportNov 5, 2026

Does ZBIO generate free cash flow?

Zenas BioPharma, Inc. (ZBIO) generated -$172.35M of free cash flow in fiscal 2025.

How much operating cash flow does ZBIO produce?

Operating cash flow was -$172.33M, before capital expenditures of $18,000.00.